Evidence map›Paper›PMID 35379328›Full record

ArticleCell & bioscience2022

UBIAD1 alleviates ferroptotic neuronal death by enhancing antioxidative capacity by cooperatively restoring impaired mitochondria and Golgi apparatus upon cerebral ischemic/reperfusion insult.

Yan Huang, Jianyang Liu, Jialin He, Zhiping Hu, Fengbo Tan, Xuelin Zhu, Fulai Yuan, Zheng Jiang

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Glycine Alleviates HMolecular neurobiology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. The cell biology of ferroptosis.Nature reviews. Molecular cell biology · 2024
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yan HuangNHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospital), Changsha, Hunan, 410008, People's Republic of China.
Jianyang LiuDepartment of Neurology, The Second Xiangya Hospital, Central South University, 139 Renming Road, Changsha, Hunan, 410011, People's Republic of China.
Jialin HeDepartment of Neurology, The Second Xiangya Hospital, Central South University, 139 Renming Road, Changsha, Hunan, 410011, People's Republic of China.
Zhiping HuDepartment of Neurology, The Second Xiangya Hospital, Central South University, 139 Renming Road, Changsha, Hunan, 410011, People's Republic of China.
Fengbo TanDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Xuelin ZhuDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Fulai Yuan *Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China. fulaiyuan2010@163.com.
Zheng Jiang *Department of Neurology, The Second Xiangya Hospital, Central South University, 139 Renming Road, Changsha, Hunan, 410011, People's Republic of China. zhengjiang187@csu.edu.cn.
Central South University · CNXiangya Hospital Central South University · CNHunan Provincial Maternal and Child Health Hospital · CNSecond Xiangya Hospital of Central South University · CN

Funding

Key Laboratory of Engineering Structures Damage and Diagnosis of Hunan Province 2021RX01National Key Research and Development Program of Hunan Province 2021sk2023National Natural Science Foundation of China 61802443National Natural Science Foundation of China 61972460National Natural Science Foundation of China 62172440National Natural Science Foundation of China 82101544Natural Science Foundation of Hunan Province 2019JJ20037Natural Science Foundation of Hunan Province 2020JJ4883Natural Science Foundation of Hunan Province 2020JJ4923Natural Science Foundation of Hunan Province 2021JJ40368
6 · The paper itself

Abstract

backgroundNeuronal death due to over-oxidative stress responses defines the pathology of cerebral ischemic/reperfusion (I/R) insult. Ferroptosis is a form of oxidative cell death that is induced by disruption of the balance between antioxidants and pro-oxidants in cells. However, the potential mechanisms responsible for cerebral I/R-induced ferroptotic neuronal death have not been conclusively determined. UBIAD1, is a newly identified antioxidant enzyme that catalyzes coenzyme Q10 (CoQ10) and vitamin K2 biosynthesis in the Golgi apparatus membrane and mitochondria, respectively. Even though UBIAD1 is a significant mediator of apoptosis in cerebral I/R challenge, its roles in ferroptotic neuronal death remain undefined. Therefore, we investigated whether ferroptotic neuronal death is involved in cerebral I/R injury. Further, we evaluated the functions and possible mechanisms of UBIAD1 in cerebral I/R-induced ferroptotic neuronal death, with a major focus on mitochondrial and Golgi apparatus dysfunctions.

resultsFerroptosis occurred in cerebral I/R. Ferroptotic neuronal death promoted cerebral I/R-induced brain tissue injury and neuronal impairment. UBIAD1 was expressed in cerebral tissues and was localized in neurons, astrocytes, and microglia. Under cerebral I/R conditions overexpressed UBIAD1 significantly suppressed lipid peroxidation and ferroptosis. Moreover, upregulated UBIAD1 protected against brain tissue damage and neuronal death by alleviating I/R-mediated lipid peroxidation and ferroptosis. However, UBIAD1 knockdown reversed these changes. Enhanced UBIAD1-mediated ferroptosis elevated the antioxidative capacity by rescuing mitochondrial and Golgi apparatus dysfunction in cerebral I/R-mediated neuronal injury. They improved the morphology and biofunctions of the mitochondria and Golgi apparatus, thereby elevating the levels of SOD, T-AOC and production of CoQ10, endothelial nitric oxide synthase (eNOS)-regulated nitric oxide (NO) generation as well as suppressed MDA generation.

conclusionsThe neuroprotective agent, UBIAD1, modulates I/R-mediated ferroptosis by restoring mitochondrial and Golgi apparatus dysfunction in damaged brain tissues and neurons, thereby enhancing antioxidative capacities. Moreover, the rescue of impaired mitochondrial and Golgi apparatus as a possible mechanism of regulating ferroptotic neuronal death is a potential treatment strategy for ischemic stroke.

Indexed as

Cerebral ischemia/reperfusionFerroptotic neuronal deathGolgi apparatusMitochondriaUBIAD1

Identifiers

PMID35379328
PMCPMC8981649
OpenAlexW4226218255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.